Gedeon Richter and exclusive negotiations for a party of Mithra

Gedeon Richter conducts exclusive negotiations with Mithra. The pharmaceutical group donates a difficult lot to the activities of the Liège company.

La société farmacie Gedeon Richter conducts exclusive negotiations with Mithra. Ce groupe international, don’t le siège social is basé in Hongrie, pourrait reprendre a party of activities in the biotech sector in Liège.

And gross difficulties, Mithra est à la recherche of representatives. The pharmaceutical company, specialized in women’s health, offers an extra luxurious offering. Elle a finale opté pour celle by Gedeon Richter.

The offer of “Estetra SRL, Neuralis SA and the specific activities of Mithra R&D SA concerns the E4 platform”, precisely the Liège company per communiqué. Estetra is la Filiale de Mithra and loading pill for contraceptive Estelle.


“Gedeon Richter’s total offer is not sufficient to enable the full compensation of all our Mithra créanciers.”

Mithra knows exactly whether Gedeon Richter’s total offer “is not sufficient to allow the full compensation of all our Mithra créanciers”. The company adds that the offer no longer exists only value creation for Mithra’s action films“.

Pret accordion

To be clear, the biotech in Liège gets one additional financing of 2.5 million euros, through a “prêt accordéon” accordé par se existing prêteurs. The financing of society can only do its activities, precisely Mithra.

Gedeon Richter is a pharmaceutical group based in Budapest and presents 50 payments, not in Belgium. La society est specialized in female health and the development of products in the field of fertility, contraception and menopause. Gedeon Richter had 11,600 employees and realized one in 2023 business cases of 2.1 billion euros.

Exclusive negotiations with Gedeon Richter jusqu’au May 10 prochain, if your parties expect an extension of the délai. Mithra’s contract remained suspended during the negotiation period.